ArticleFrontiers in oncology2026
Cryoablation as an organ-preserving therapy for low rectal cancer a comprehensive protocol and institutional perspective.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cryoablation is an interventional approach which induces localized tumor destruction. It is used to treat patients with low rectal cancer (LRC) to preserve their sphincters and avoid permanent colostomies. This article provides a systematic illustration of cryoablation for LRC, encompassing its core technical principles, indications and contraindications. Furthermore, it elaborates on pre-procedural preparation, standardized operative steps, post-cryoablation management, potential complications and mitigation and long-term follow-up protocols. Rooted in five decades of institutional experience, we seek to standardize the procedure and establish it as a credible, evidence-based alternative approach for well-selected patients, especially those who are not candidates for or who decline radical resection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.